Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats

Fa Yauh Lee, Wang Suh-Sang, Tsai Yang-Te, Lin Hwai-Jeng, Lin Han-Chieh, Chu Chi-Jen, Wu Shwu-Ling, Tai Chung-Ching, Lee Shou-Dong

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background/aims: Portal hypertension and hyperdynamic circulation (i.e. generalized vasodilation and increased cardiac output and regional organ blood flows) may play an important role in the development of portal hypertensive gastropathy. This study investigated the effect of chronic administration of aminoguanidine, a selective inducible nitric oxide synthase inhibitor, to portal hypertensive rats on hemodynamics and the development of portal hypertensive gastropathy. Methods: Partial portal vein-ligated or sham-operated rats were randomly assigned to receive either placebo (distilled water) or aminoguanidine (~ 100 mg/kg per day subcutaneously) for 2 days prior to and 14 days. Hemodynamic studies with a thermodilution technique and gastric morphometric analysis were performed at 14 days after the operation. Results: In rats given placebo, portal vein-ligated rats had a significantly lower mean arterial pressure and systemic vascular resistance associated with a significantly higher cardiac index and portal pressure than sham-operated rats (p <0.05). In portal vein-ligated rats aminoguanidine induced a significant increase in mean arterial pressure and systemic vascular resistance accompanied by a significant decrease in cardiac index (p <0.05) without changes in portal pressure (p > 0.05). Despite persistence of portal hypertension, the aminoguanidine-treated portal vein-ligated rats had similar mean arterial pressure, cardiac index, and systemic vascular resistance as seen in placebo-treated sham-operated rats. The mean cross-sectional area of gastric mucosal vessels was significantly higher in placebo-treated portal vein-ligated than in placebo-treated sham-operated rats (p <0.05). Treatment with aminoguanidine did not induce changes in the mean cross-sectional area of gastric mucosal vessels in either portal vein-ligated or sham-operated rats (p > 0.05). Conclusions: The results show that in portal hypertensive rats long-term aminoguanidine therapy corrects the hyperdynamic circulation without inducing changes in portal pressure and ameliorating the development of portal hypertensive gastropathy. This study suggests that, instead of correcting hyperdynamic circulation, treatment of portal hypertensive gastropathy should be aimed at reducing portal pressure.

Original languageEnglish
Pages (from-to)687-693
Number of pages7
JournalJournal of Hepatology
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 1997
Externally publishedYes

Fingerprint

Portal Hypertension
Portal Vein
Portal Pressure
Placebos
Vascular Resistance
Stomach
Arterial Pressure
Hemodynamics
pimagedine
Thermodilution
Regional Blood Flow
Nitric Oxide Synthase Type II
Vasodilation
Cardiac Output
Water
Therapeutics

Keywords

  • aminoguanidine
  • hyperdynamic circulation
  • nitric oxide
  • portal hypertension
  • portal hypertensive gastropathy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. / Lee, Fa Yauh; Suh-Sang, Wang; Yang-Te, Tsai; Hwai-Jeng, Lin; Han-Chieh, Lin; Chi-Jen, Chu; Shwu-Ling, Wu; Chung-Ching, Tai; Shou-Dong, Lee.

In: Journal of Hepatology, Vol. 26, No. 3, 03.1997, p. 687-693.

Research output: Contribution to journalArticle

Lee, Fa Yauh ; Suh-Sang, Wang ; Yang-Te, Tsai ; Hwai-Jeng, Lin ; Han-Chieh, Lin ; Chi-Jen, Chu ; Shwu-Ling, Wu ; Chung-Ching, Tai ; Shou-Dong, Lee. / Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. In: Journal of Hepatology. 1997 ; Vol. 26, No. 3. pp. 687-693.
@article{80eb958ab7fe4315a9785c63769dd8d8,
title = "Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats",
abstract = "Background/aims: Portal hypertension and hyperdynamic circulation (i.e. generalized vasodilation and increased cardiac output and regional organ blood flows) may play an important role in the development of portal hypertensive gastropathy. This study investigated the effect of chronic administration of aminoguanidine, a selective inducible nitric oxide synthase inhibitor, to portal hypertensive rats on hemodynamics and the development of portal hypertensive gastropathy. Methods: Partial portal vein-ligated or sham-operated rats were randomly assigned to receive either placebo (distilled water) or aminoguanidine (~ 100 mg/kg per day subcutaneously) for 2 days prior to and 14 days. Hemodynamic studies with a thermodilution technique and gastric morphometric analysis were performed at 14 days after the operation. Results: In rats given placebo, portal vein-ligated rats had a significantly lower mean arterial pressure and systemic vascular resistance associated with a significantly higher cardiac index and portal pressure than sham-operated rats (p <0.05). In portal vein-ligated rats aminoguanidine induced a significant increase in mean arterial pressure and systemic vascular resistance accompanied by a significant decrease in cardiac index (p <0.05) without changes in portal pressure (p > 0.05). Despite persistence of portal hypertension, the aminoguanidine-treated portal vein-ligated rats had similar mean arterial pressure, cardiac index, and systemic vascular resistance as seen in placebo-treated sham-operated rats. The mean cross-sectional area of gastric mucosal vessels was significantly higher in placebo-treated portal vein-ligated than in placebo-treated sham-operated rats (p <0.05). Treatment with aminoguanidine did not induce changes in the mean cross-sectional area of gastric mucosal vessels in either portal vein-ligated or sham-operated rats (p > 0.05). Conclusions: The results show that in portal hypertensive rats long-term aminoguanidine therapy corrects the hyperdynamic circulation without inducing changes in portal pressure and ameliorating the development of portal hypertensive gastropathy. This study suggests that, instead of correcting hyperdynamic circulation, treatment of portal hypertensive gastropathy should be aimed at reducing portal pressure.",
keywords = "aminoguanidine, hyperdynamic circulation, nitric oxide, portal hypertension, portal hypertensive gastropathy",
author = "Lee, {Fa Yauh} and Wang Suh-Sang and Tsai Yang-Te and Lin Hwai-Jeng and Lin Han-Chieh and Chu Chi-Jen and Wu Shwu-Ling and Tai Chung-Ching and Lee Shou-Dong",
year = "1997",
month = "3",
doi = "10.1016/S0168-8278(97)80436-9",
language = "English",
volume = "26",
pages = "687--693",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats

AU - Lee, Fa Yauh

AU - Suh-Sang, Wang

AU - Yang-Te, Tsai

AU - Hwai-Jeng, Lin

AU - Han-Chieh, Lin

AU - Chi-Jen, Chu

AU - Shwu-Ling, Wu

AU - Chung-Ching, Tai

AU - Shou-Dong, Lee

PY - 1997/3

Y1 - 1997/3

N2 - Background/aims: Portal hypertension and hyperdynamic circulation (i.e. generalized vasodilation and increased cardiac output and regional organ blood flows) may play an important role in the development of portal hypertensive gastropathy. This study investigated the effect of chronic administration of aminoguanidine, a selective inducible nitric oxide synthase inhibitor, to portal hypertensive rats on hemodynamics and the development of portal hypertensive gastropathy. Methods: Partial portal vein-ligated or sham-operated rats were randomly assigned to receive either placebo (distilled water) or aminoguanidine (~ 100 mg/kg per day subcutaneously) for 2 days prior to and 14 days. Hemodynamic studies with a thermodilution technique and gastric morphometric analysis were performed at 14 days after the operation. Results: In rats given placebo, portal vein-ligated rats had a significantly lower mean arterial pressure and systemic vascular resistance associated with a significantly higher cardiac index and portal pressure than sham-operated rats (p <0.05). In portal vein-ligated rats aminoguanidine induced a significant increase in mean arterial pressure and systemic vascular resistance accompanied by a significant decrease in cardiac index (p <0.05) without changes in portal pressure (p > 0.05). Despite persistence of portal hypertension, the aminoguanidine-treated portal vein-ligated rats had similar mean arterial pressure, cardiac index, and systemic vascular resistance as seen in placebo-treated sham-operated rats. The mean cross-sectional area of gastric mucosal vessels was significantly higher in placebo-treated portal vein-ligated than in placebo-treated sham-operated rats (p <0.05). Treatment with aminoguanidine did not induce changes in the mean cross-sectional area of gastric mucosal vessels in either portal vein-ligated or sham-operated rats (p > 0.05). Conclusions: The results show that in portal hypertensive rats long-term aminoguanidine therapy corrects the hyperdynamic circulation without inducing changes in portal pressure and ameliorating the development of portal hypertensive gastropathy. This study suggests that, instead of correcting hyperdynamic circulation, treatment of portal hypertensive gastropathy should be aimed at reducing portal pressure.

AB - Background/aims: Portal hypertension and hyperdynamic circulation (i.e. generalized vasodilation and increased cardiac output and regional organ blood flows) may play an important role in the development of portal hypertensive gastropathy. This study investigated the effect of chronic administration of aminoguanidine, a selective inducible nitric oxide synthase inhibitor, to portal hypertensive rats on hemodynamics and the development of portal hypertensive gastropathy. Methods: Partial portal vein-ligated or sham-operated rats were randomly assigned to receive either placebo (distilled water) or aminoguanidine (~ 100 mg/kg per day subcutaneously) for 2 days prior to and 14 days. Hemodynamic studies with a thermodilution technique and gastric morphometric analysis were performed at 14 days after the operation. Results: In rats given placebo, portal vein-ligated rats had a significantly lower mean arterial pressure and systemic vascular resistance associated with a significantly higher cardiac index and portal pressure than sham-operated rats (p <0.05). In portal vein-ligated rats aminoguanidine induced a significant increase in mean arterial pressure and systemic vascular resistance accompanied by a significant decrease in cardiac index (p <0.05) without changes in portal pressure (p > 0.05). Despite persistence of portal hypertension, the aminoguanidine-treated portal vein-ligated rats had similar mean arterial pressure, cardiac index, and systemic vascular resistance as seen in placebo-treated sham-operated rats. The mean cross-sectional area of gastric mucosal vessels was significantly higher in placebo-treated portal vein-ligated than in placebo-treated sham-operated rats (p <0.05). Treatment with aminoguanidine did not induce changes in the mean cross-sectional area of gastric mucosal vessels in either portal vein-ligated or sham-operated rats (p > 0.05). Conclusions: The results show that in portal hypertensive rats long-term aminoguanidine therapy corrects the hyperdynamic circulation without inducing changes in portal pressure and ameliorating the development of portal hypertensive gastropathy. This study suggests that, instead of correcting hyperdynamic circulation, treatment of portal hypertensive gastropathy should be aimed at reducing portal pressure.

KW - aminoguanidine

KW - hyperdynamic circulation

KW - nitric oxide

KW - portal hypertension

KW - portal hypertensive gastropathy

UR - http://www.scopus.com/inward/record.url?scp=0343683298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343683298&partnerID=8YFLogxK

U2 - 10.1016/S0168-8278(97)80436-9

DO - 10.1016/S0168-8278(97)80436-9

M3 - Article

C2 - 9075678

AN - SCOPUS:0343683298

VL - 26

SP - 687

EP - 693

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 3

ER -